Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19.
Front Cardiovasc Med
; 7: 593061, 2020.
Article
in English
| MEDLINE | ID: covidwho-1485041
ABSTRACT
Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Front Cardiovasc Med
Year:
2020
Document Type:
Article
Affiliation country:
Fcvm.2020.593061
Similar
MEDLINE
...
LILACS
LIS